It was not powered to look at patient-centered or patient-level effects such as mortality or other health outcomes, but many of the secondary outcomes showed a nonsignificant trend toward benefit for propranolol.
← all excerpts
Propranolol As an Anxiolytic to Reduce the Use of Sedatives for Critically Ill Adults Receiving Mechanical Ventilation (PROACTIVE): An Open-Label Randomized Controlled Trial.
1
—
—